Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - isoprenaline hydrochloride - solution for injection - isoprenaline hydrochloride 0.2 mg/ml - cardiac therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - isoprenaline hydrochloride 0.02 mg/ml - solution for injection - 0.2 mg/10ml - active: isoprenaline hydrochloride 0.02 mg/ml excipient: citric acid monohydrate sodium bisulfite sodium chloride sodium citrate dihydrate water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

international medication systems (uk) ltd - isoprenaline hydrochloride - solution for inj/inf - 20 microgram/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: hydrochloric acid; sodium citrate dihydrate; citric acid; sodium chloride; water for injections; sodium hydroxide; disodium edetate - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - isoprenaline sulfate - solution for injection - 20microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - isoprenaline sulfate - solution for injection - 50microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - isoprenaline sulfate - solution for injection - 100microgram/1ml